Clinical Trial Update: A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating an extended-release carvedilol sulfate formulation for hypertension; the current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Extended-Release Carvedilol Sulfate (carvedilol sulfate)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Hypertension | Phase 3 | Status: UNKNOWN